Micronutrient mixture did not show a survival benefit in a small glioblastoma trial
Survival results were similar numerically, but the trial did not establish either benefit or equivalence for supplements added to postoperative chemoradiation.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In patients newly diagnosed with glioblastoma, adding a micronutrient mixture to postoperative chemoradiation did not demonstrate a statistically significant improvement in overall survival compared with placebo. The reported survival figures were close, but that does not prove the treatments were equivalent. The authors say larger, adequately powered trials are needed to clarify any effect.
This abstract-based summary lacks survival confidence intervals and does not identify the reported figures as means or medians. The authors emphasize the need for sufficiently powered trials.
What researchers found
Reported overall survival
Micronutrient mixture versus placebo; Kaplan–Meier analysis, p = 0.752. The abstract does not report the duration of survival follow-up.
What was tested
The capsules combined plant extracts and other micronutrients, including curcumin, selenium and lycopene. Supplementation began alongside chemoradiation after neurosurgery, so the trial assessed an addition to that treatment context.
What uncertainty remains
The nonsignificant survival comparison leaves uncertainty about the size and direction of any treatment effect. It also offers no basis for identifying which patients, if any, might benefit from the mixture.
The original publication
Overall Survival of Glioblastoma Patients Treated With a Combination of 7 Micronutrients: A Nutraceutical Trial.
Rooprai HK, Lawrence P, Ashkan K et al.
Anticancer Res · 2026
- PubMed ID
- 41760279
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.